Abstract

Familial hypercholesterolaemia is an inherited disorder that substantially increases risk of coronary artery disease.1,2 Recent population data show that the heterozygous and homozygous forms of familial hypercholesterolaemia affect one in 2001 and one in 160 000–300 000 people,3 respectively, worldwide. Plasma concentrations of LDL cholesterol (LDL-C) are increased in the disorder because of hypocatabolism of LDL particles by the liver, which is related to the severity of underlying genetic mutations mostly affecting the LDL receptor gene.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.